July 22, 2024 03:33 PM EDTUpdated 04:29 PM

WuXi AppTec more than tripled lobbying spend as Biosecure Act advanced in Congress

Jared Whitlock

Features Editor

Zachary Brennan

Senior Editor

China’s WuXi AppTec spent at least $360,000 lobbying on the Biosecure Act and other bills before Congress in the second quarter, significantly upping its lobbying …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

WuXi AppTec more than tripled lobbying spend as Biosecure Act advanced in Congress

Jared Whitlock

Features Editor

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Trump names Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, Surgeon General picks

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

FDA vaccine chief Peter Marks pledges to stay as long as he's welcome

Patient dies in Neurogene's Rett syndrome study

Are programs with compounded GLP-1s safe for your population?

WuXi AppTec more than tripled lob­by­ing spend as Biose­cure Act ad­vanced in Con­gress

Features Editor

Senior Editor

Sign up to read this article for free.

WuXi AppTec more than tripled lobbying spend as Biosecure Act advanced in Congress